Gillian C. Ivers-Read
2011
In 2011, Gillian C. Ivers-Read earned a total compensation of $659.7K as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 66% increase compared to previous year.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Option Awards | $149,661 |
| Salary | $345,833 |
| Other | $24,182 |
| Total | $659,676 |
Ivers-Read received $345.8K in salary, accounting for 52% of the total pay in 2011.
Ivers-Read also received $140K in bonus, $149.7K in option awards and $24.2K in other compensation.
Rankings
In 2011, Gillian C. Ivers-Read's compensation ranked 7,168th out of 10,747 executives tracked by ExecPay. In other words, Ivers-Read earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,168 out of 10,747 | 33rd |
Division Manufacturing | 2,615 out of 3,960 | 34th |
Major group Chemicals And Allied Products | 628 out of 1,033 | 39th |
Industry group Drugs | 431 out of 781 | 45th |
Industry Pharmaceutical Preparations | 335 out of 571 | 41st |
Source: SEC filing on April 29, 2013.
Ivers-Read's colleagues
We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2011.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019